Cargando…

XRCC3 Thr241Met Is Associated with Response to Platinum-Based Chemotherapy but Not Survival in Advanced Non-Small Cell Lung Cancer

BACKGROUND: A lot of studies have investigated the correlation between x-ray repair cross-complementing group 3 (XRCC3) Thr241Met polymorphism and clinical outcomes in non-small cell cancer (NSCLC), while the conclusion is still conflicting. MATERIALS AND METHODS: We conducted this meta-analysis to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Mantang, Xu, Lei, Yang, Xin, Ding, Xiangxiang, Hu, Jingwen, Jiang, Feng, Xu, Lin, Yin, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792919/ https://www.ncbi.nlm.nih.gov/pubmed/24116196 http://dx.doi.org/10.1371/journal.pone.0077005

Ejemplares similares

XRCC3 Thr241Met Polymorphism and Clinical Outcomes of NSCLC Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis
por: Shen, Xiao-yong, et al.
Publicado: (2013)

XRCC3 Thr241Met polymorphism and ovarian cancer risk: a meta-analysis
por: Yan, Yulan, et al.
Publicado: (2013)

XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis
por: Zhan, Ping, et al.
Publicado: (2013)

XRCC3 Thr241Met Polymorphism is not Associated with Lung Cancer Risk in a Romanian Population
por: CATANA, ANDREEA, et al.
Publicado: (2016)

DNA repair gene XRCC3 Thr241Met polymorphism and susceptibility to glioma: A case-control study
por: XU, GAOFENG, et al.
Publicado: (2014)

Association between the XRCC3 Thr241Met Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis
por: Sahami-Fard, Mohammad Hossein, et al.
Publicado: (2016)

Ethnicity-stratified analysis of the association between XRCC3 Thr241Met polymorphism and leukemia: an updated meta-analysis
por: Xie, Zhengjun, et al.
Publicado: (2021)

Predictive Value of XPD Polymorphisms on Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Qiu, Mantang, et al.
Publicado: (2013)

XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer
por: He, Yanjing, et al.
Publicado: (2018)

A literature review and systematic meta-analysis on XRCC3 Thr241Met polymorphism associating with susceptibility of oral cancer
por: Fan, Jianlin, et al.
Publicado: (2019)

Association between XRCC3 p.Thr241Met polymorphism and risk of glioma: A systematic review and meta-analysis
por: Tan, Shing Cheng, et al.
Publicado: (2022)

Association Between XRCC3 Thr241Met Polymorphism and Risk of Breast Cancer: Meta-Analysis of 23 Case-Control Studies
por: Chai, Fan, et al.
Publicado: (2015)

Association of XRCC3 18067 C>T (Thr241Met) polymorphism with risk of cervical and ovarian cancers: A systematic review and meta-analysis
por: Karimi-Zarchi, Mojgan, et al.
Publicado: (2019)

Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies
por: Dashti, Sepideh, et al.
Publicado: (2019)

Association Between X-Ray Cross-Complementing Group 3 (XRCC3) Thr241Met Polymorphism and Risk of Thyroid Cancer: A Meta-Analysis
por: Lu, Wenying, et al.
Publicado: (2015)

Comment on: “Association Between the XRCC3 Thr241Met Polymorphism and Risk of Colorectal Cancer: A Meta-Analysis of 5,193 Cases and 6,645 Controls”
por: Sahami-Fard, Mohammad Hossein, et al.
Publicado: (2016)

DNA Repair Mechanism Gene, XRCC1A (Arg194Trp) but not XRCC3 (Thr241Met) Polymorphism Increased the Risk of Breast Cancer in Premenopausal Females: A Case–Control Study in Northeastern Region of India
por: Devi, K. Rekha, et al.
Publicado: (2017)

Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy
por: Yuan, Zhengrong, et al.
Publicado: (2015)

XRCC1 polymorphism and overall survival in ovarian cancer patients treated with platinum-based chemotherapy: A systematic review and MOOSE-compliant meta-analysis
por: Zhang, Zhuo, et al.
Publicado: (2018)

Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway Inhibition
por: Xu, Manman, et al.
Publicado: (2022)

THR Simulator – the software for generating radiographs of THR prosthesis
por: Wu, Tai-Yin, et al.
Publicado: (2009)

ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy
por: Liblab, Salisa, et al.
Publicado: (2020)

Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis
por: Zhang, Ningning, et al.
Publicado: (2020)

Circles within circles: crosstalk between protein Ser/Thr/Tyr-phosphorylation and Met oxidation
por: Rao, R Shyama Prasad, et al.
Publicado: (2013)

Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement
por: Li, Dan-Juan, et al.
Publicado: (2017)

Nanophthalmos patient with a THR518MET mutation in MYRF, a case report
por: Hagedorn, Joshua, et al.
Publicado: (2020)

Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B
por: Lu, Linna, et al.
Publicado: (2023)

PSEN2 Thr421Met Mutation in a Patient with Early Onset Alzheimer’s Disease
por: Yang, YoungSoon, et al.
Publicado: (2022)

GRIA3 p.Met661Thr variant in a female with developmental epileptic encephalopathy
por: Okano, Satomi, et al.
Publicado: (2023)

Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk
por: Kaur, Jagjeet, et al.
Publicado: (2020)

Significant value of XRCC2 and XRCC9 expression in the prognosis of human ovarian carcinoma
por: Liu, Yi, et al.
Publicado: (2021)

Analysis of Thr12Met and Ala1144Thr Mutations of the ATP13A2 Gene in Parkinson’s Disease Patients in Xinjiang Uygur and Han Ethnic Groups
por: Li, Guihua, et al.
Publicado: (2014)

Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer
por: Xu, Youtao, et al.
Publicado: (2015)

Kir2.2 p.Thr140Met: a genetic susceptibility to sporadic periodic paralysis
por: FAN, CHUNXIANG, et al.
Publicado: (2018)

High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot
por: Croci, Susanna, et al.
Publicado: (2020)

A Case of Congenital Nephrogenic Diabetes Insipidus Caused by Thr108Met Variant of Aquaporin 2
por: Ma, Lina, et al.
Publicado: (2020)

Myocardial Infarction and AGT p.Thr174Met Polymorphism: A Meta-Analysis of 7657 Subjects
por: Li, Yan-yan, et al.
Publicado: (2021)

A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer
por: Mandegari, Mohammad, et al.
Publicado: (2021)

Clinical significance of MET gene amplification in metastatic or locally advanced gastric cancer treated with first-line fluoropyrimidine and platinum combination chemotherapy
por: Seo, Seyoung, et al.
Publicado: (2019)

The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer
por: Zhang, Jian-Wei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_buo45hr6abloh8s5bpfh29uago